Hew Health Field Notes
Dispatch 20 November 2026 5 min read

Peptide Protocol Review Visit: What to Expect

If you are on a peptide protocol, the review visit is where the clinical work actually happens. The first prescription is the easy part. What you do at month three, month six, and the first time something feels off is what separates a thoughtful protocol from a bottle of stuff

Peptide Protocol Review Visit: What to Expect
Field Notes · Vol. I 20.11.2026

If you are on a peptide protocol, the review visit is where the clinical work actually happens. The first prescription is the easy part. What you do at month three, month six, and the first time something feels off is what separates a thoughtful protocol from a bottle of stuff sitting in your refrigerator.

In our practice, a peptide protocol review is a dedicated visit, usually 30 to 45 minutes, built around one question: is this protocol doing what we hoped, at a dose your body is tolerating well, and should we continue, adjust, or stop? That is the whole job. Below is what the visit actually involves, who benefits from one, and the moments when you should put it on the calendar.

What Actually Happens During the Visit

A proper review is not a refill rubber-stamp. We sit down with your current regimen in front of us (every peptide, dose, timing, injection site, cycling pattern) and compare it against what you reported at baseline and what your labs and symptoms say now.

Expect your clinician to go through four areas in depth.

1. Subjective response

We ask specific questions, not general ones. Sleep onset and wake pattern. Recovery from training sessions. Joint stiffness in the morning. Appetite signaling, energy at 3pm, libido, mood stability, skin and hair changes, injection-site tenderness. If you are on a growth hormone secretagogue, we want to know about water retention in your hands, any tingling in the fingers, and whether your fasting hunger patterns have shifted.

2. Objective data

Depending on the peptide class, we review labs drawn in the preceding two to three weeks. For growth hormone-related protocols, that typically includes IGF-1, fasting glucose, HbA1c, and a fasting insulin. For protocols aimed at metabolic support, we track a lipid panel, liver enzymes, and sometimes a comprehensive metabolic panel. Body composition data (DEXA or a validated bioimpedance scan) is more useful than scale weight, and we will often look at resting heart rate and blood pressure trends from your wearable if you use one.

3. Protocol adjustments

Doses go up, doses come down, timing shifts, cycles get introduced or extended. If IGF-1 is climbing above the range we agreed on, we titrate down. If sleep improved but joint recovery stalled, we discuss whether another agent is appropriate or whether training volume is the actual variable. Sometimes the right move is a washout period. We say so.

4. Supply, sourcing, and administration technique

We confirm you are getting peptides from a licensed compounding pharmacy, that storage has been correct (most require refrigeration after reconstitution), and that your injection technique has not drifted. Small technique issues create big absorption variability, and it is worth five minutes to watch someone draw up a dose.

Who Should Be Having These Visits

Anyone on an active peptide protocol should have a scheduled review cadence built in from day one. In our practice we typically see patients at 6 to 8 weeks after initiation, then every 12 weeks while on therapy, with labs timed to the visit. That cadence covers most people on protocols for recovery, body composition support within a Weight Management plan, sleep architecture, or adjunctive use alongside hormone optimization.

Patients who particularly benefit from a structured review schedule include:

  • Anyone running more than one peptide simultaneously, where interactions and cumulative effects need a clinician's eye
  • Patients over 50, where IGF-1 targets and glucose handling deserve closer attention
  • Patients with a personal or family history of cancer, where we are more conservative about growth-signaling peptides and want to re-confirm the risk-benefit at each visit
  • Athletes in-season, where timing around competition and testing matters
  • Patients who have been on the same protocol for more than six months without a formal reassessment

When You Should Pick Up the Phone Between Scheduled Visits

The scheduled cadence is a floor, not a ceiling. Call us and ask for an earlier review if any of the following happens.

New or worsening side effects. Persistent injection-site reactions beyond mild redness. Numbness or tingling in the hands that does not resolve. New headaches. Fluid retention that bothers you. GI changes that last more than a few days. Mood shifts you did not have before starting.

A change in your other medications. Starting a new prescription, particularly anything that affects glucose, thyroid, or cortisol, can change how a peptide behaves. The review visit is where we reconcile everything.

A plateau or regression. If the benefit you were feeling at week six is gone by week sixteen, that is data. Sometimes it means the dose needs adjusting. Sometimes it means your body has adapted and a cycle break is appropriate. Sometimes the peptide was never doing what we hoped and we should redirect your time and money elsewhere. All three answers are legitimate.

A major life change. New training program, significant weight change, a new diagnosis, surgery on the calendar, pregnancy planning, or a cross-country move that changes your sleep and stress baseline. Any of these warrants a sit-down before your next scheduled visit.

You are considering stopping. Please do not just stop. Some peptides are fine to discontinue cold. Others benefit from a taper or a planned transition. A 20-minute visit prevents a month of feeling worse than you need to.

What a Good Review Visit Should Leave You With

You should walk out (or log off, for telehealth visits) with three things clearly documented: the specific protocol you are on until the next review, the labs or measurements we want before that review, and the date it is scheduled. If any of those are vague, ask. Concierge medicine earns its keep in the specificity of the plan, not in the warmth of the waiting room.

You should also have a clear understanding of what we are watching for and what would change the plan. "We are continuing your current dose, rechecking IGF-1 and fasting glucose in ten weeks, and if IGF-1 is above 220 we will drop the evening dose by 25%" is a plan. "Let's see how you feel" is not.

A Note on Expectations

Peptides are protocols, not cures. They are tools we use alongside sleep, training, nutrition, hormone optimization where appropriate, and the rest of a well-run health plan. The review visit is where we keep that honest. If something is working, we keep going. If it is not, we change course without sentimentality about the previous plan.

Peptide therapies discussed in this article are not FDA-approved for the uses described. They are prescribed through licensed compounding pharmacies under the clinical judgment of your physician, and every protocol carries risks that should be reviewed in person before starting or continuing therapy.

If you are currently on a peptide protocol you have not reviewed in the last three months, or you are considering starting one and want to understand what ongoing care actually looks like, contact our team to request a consultation. We will tell you honestly whether a protocol makes sense for you and, if it does, how we will keep an eye on it.


Related from Hew Health